Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma

NCT01686321 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Aggressive Lymphoma

Interventions

DRUG: Bendamustine and subcutaneous rituximab

Sponsor

University of Göttingen

Collaborators

[object Object]
[object Object]